David A. Metcalfe - 02 Nov 2021 Form 4 Insider Report for NEXTGEN HEALTHCARE, INC.

Role: Chief Technology Officer
Signature: /s/ Jeffrey D. Linton, Attorney-in-Fact for David A. Metcalfe
Issuer symbol: N/A
Transactions as of: 02 Nov 2021
Net transactions value: $0
Form type: 4
Filing time: 04 Nov 2021, 16:23:07 UTC
Previous filing: 28 Oct 2021
Next filing: 28 Dec 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	NXGN	Common Stock	Award	$0	+34,425	+28%	$0.000000	159,261	02 Nov 2021	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	NXGN	Performance Stock Units	Award	$0	+74,707	+79%	$0.000000	169,541	02 Nov 2021	Common Stock	74,707		Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The shares of restricted stock vest over three years in annual increments as follows: 1/3 vest on the first anniversary of the date of grant, 1/3 vest on the second anniversary of the date of grant, and 1/3 vest on the third anniversary of the date of grant, subject to continued service through each vesting date.
F2	The performance share units that vest upon both the attainment of four separate pre-determined stock price milestones and continued service over a period of three years commencing September 22, 2021.